Ankylosing Spondylitis Market Size Is Projected to Reach $8.45 Billion By 2028 |Polaris Market Research

News provided by

Mar 25, 2021, 08:32 ET

NEW YORK, March 25, 2021 /PRNewswire/ -- The global ankylosing spondylitis market size is expected to reach USD 8.45 billion by 2028 according to a new study conducted by Polaris Market Research. The market is anticipated to register a CAGR: 8.5% from 2021 – 2028. Increasing cases of ankylosing spondylitis coupled with growing awareness regarding the diagnostics and treatments for this disease are the major factors augmenting the market growth. In addition to this, improving healthcare infrastructure and increasing government initiatives to reduce the cases of such diseases are further contribute to the overall development of the market. Furthermore, rapid technological advancements in the field and favorable reimbursement policies are turning out in the favor of the market growth.

Request for a sample copy at: https://www.polarismarketresearch.com/industry-analysis/ankylosing-spondylitis-market/request-for-sample

Key Highlights of Ankylosing Spondylitis Market

Based on product type, the Humira segment contributed the largest revenue share in the ankylosing spondylitis market. The segment's growth is attributed to favorable drug pricing and lack of biosimilar competition in major economies.
Continual research & development programs initiated by the leading industry players to improve the available treatments and introduce newer options for a speedy recovery of patients significantly impact the overall growth of the market.
Patients infected with ankylosing spondylitis need to be extra careful amid COVID-19. Pandemics. Recent studies show that patients detected with ankylosing spondylitis are prone to get affected by COVID-19 infection.

Rising prevalence of ankylosing spondylitis with faulty lifestyles coupled with patient awareness and new product approvals driving the market forward. According to the recent population estimates the prevalence rate of ankylosing spondylitis in the U.S. is around 0.2-0.5 percent and based on market data from multiple countries the global incidence rate was stood at 0.4-14 per 100,000 individuals.

Regional Developments:

North America accounted for the major revenue share in the ankylosing spondylitis market and is projected to continue its rapid growth during the forecast period. The regional market growth is driven by a rise in incidences of target diseases and increasing adoption of the latest technologies for better treatment options. On the other side, Europe, followed by the Asia Pacific region is expected to witness the fastest growth rate over the forecast period. Increasing geriatric population and increasing government efforts to limit the cases of ankylosing spondylitis in these regions.

Have Any Query Or Specific Requirement? Feel Free to Ask Our Industry Experts at: https://www.polarismarketresearch.com/industry-analysis/ankylosing-spondylitis-market/speak-to-analyst

Competitive Outlook:

Some of the key players operating in the global ankylosing spondylitis market are Merck & Co., Inc., Amgen, Inc., AbbVie, Inc., Eli Lilly and Company, Pfizer, Inc., UCB, Inc., Johnson & Johnson Services, Inc., and Novartis AG. Leading players present in the market are heavily investing in research and development activities to have better treatment options. A rise in new product launches along with increasing acquisitions, partnerships, and mergers are some of the latest trends observed in the market.

Target Audience

Supply Side: Pharmaceutical and Biopharmaceutical Companies
Demand Side: Clinics, Hospital, and Healthcare Centers
Regulatory Side: World Health Organization

Polaris Market Research has segmented the Ankylosing Spondylitis Market report on the basis of drug, treatment type, and region:

Ankylosing Spondylitis, Drug Outlook (Revenue – USD Million, 2016 – 2028)

Cosentyx
Humira
Simponi
Remicade
Enbrel
Cimzia
Others

Ankylosing Spondylitis, Treatment Type Outlook (Revenue – USD Million, 2016 – 2028)

Painkillers and non-steroidal anti-inflammatory drugs (NSAIDs)
Disease-modifying anti-rheumatic drugs (DMARDs)
Biological therapies
Steroids
Physical therapies
Surgery

Ankylosing Spondylitis, Regional Outlook (Revenue – USD Million, 2016 – 2027)

North America

U.S.
Canada

Europe

France
Germany
UK
Italy
Spain
Netherlands
Austria

Asia Pacific

China
India
Japan
Malaysia
South Korea
Indonesia

Central & South America

Mexico
Brazil
Argentina

Middle East & Africa

UAE
Saudi Arabia
Israel
South Africa

List of Key Players of Ankylosing Spondylitis Market

AbbVie, Inc.
Amgen, Inc.
Novartis AG
Pfizer, Inc.
Eli Lilly and Company
UCB, Inc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH

*Note: Additional companies can be included on request

Buy this report: https://www.polarismarketresearch.com/checkouts/7671

Find more research reports on Healthcare Industry by Polaris Market Research

Bone Grafts and Substitutes Market Size, Share & Trends Analysis Report By Material Type (Natural, Synthetic); By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone); By Region - Segment Forecast, 2020 – 2026

Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Kits & Reagents, Services); By Technology (PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques, Enzymatic Methods); By Application; By End Use; By Regions; Segment Forecast, 2020 - 2027

Biopharma Cold Chain Logistics Market Share, Size, Trends, Industry Analysis Report, By Component (Storage [Warehouse, Refrigerated Container], Transportation [Sea Freight Logistics, Air Freight Logistics, Overland Logistics], Monitoring Components); By Regions; Segment Forecast, 2020 – 2027

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-917-985-9017
Email: [email protected]
Web: https://www.polarismarketresearch.com/
Follow US: LinkedIn | twitter